Top Losers

MGC Diagnostics (NASDAQ: MGCD) shares tumbled 16.09% to $6.83 after the company reported Q3 GAAP loss of $0.21 per share on revenue of $6.60 million. AngloGold Ashanti (NYSE: AU) declined 12.40% to $13.57 after the company proposed the corporate restructure of international mining operations under...

GT Advanced Technologies (NASDAQ: GTAT) shares slipped 7.70% to $13.79 in pre-market trading. Goldman Sachs downgraded GT Advanced Technologies from Buy to Neutral and lowered the price target from $20.00 to $14.00. Krispy Kreme Doughnuts (NYSE: KKD) shares dipped 4.88% to $16.75 in pre-market...

MaxLinear (NYSE: MXL) shares dipped 14.60% to $7.49 after the company lowered its Q3 revenue forecast. FuelCell Energy (NASDAQ: FCEL) fell 9.74% to $2.41 after the company reported downbeat quarterly revenue. However, the company reported in-line loss. The company also announced an agreement to...

Francesca's Holdings (NASDAQ: FRAN) shares slipped 10.81% to $12.46 in pre-market trading after the company reported weaker-than-expected second-quarter results and lowered its earnings forecast for fiscal year 2014. FuelCell Energy (NASDAQ: FCEL) shares dipped 10.11% to $2.40 in pre-market trading...

Callon Petroleum Company (NYSE: CPE) shares slipped 7.96% to $9.26 after the company announced the commencement of public offering of 12.5 million shares of common stock. Kamada (NASDAQ: KMDA) shares dropped 7.13% to $5.34 after falling 1.20% on Friday. Hyperion Therapeutics (NASDAQ: HPTX) shares...

Kamada (NASDAQ: KMDA) shares slipped 4.35% to $5.50 in pre-market trading after falling 1.20% on Friday. Ford Motor Co (NYSE: F) shares dipped 1.93% to $16.81 in pre-market trading. Analysts at Morgan Stanley downgraded Ford from Overweight to Underweight and lowered the target price from $17 to $...

Recro Pharma (NASDAQ: REPH) dipped 46.41% to $3.06 after the company reported that its trial study is not seen reaching statistical significance. Golden Minerals Company (NYSE: AUMN) declined 25.74% to $0.75 after the company announced a proposed public offering of common stock and warrants....

Quiksilver (NYSE: ZQK) shares slipped 7.07% to $2.63 in pre-market trading after the company reported downbeat results for thousand third quarter. The company posted an loss of $0.20 per share on revenue of $395.7 million. However, analysts were expecting earnings of $0.03 per share on revenue of $...

Matrix Service Company (NASDAQ: MTRX) shares dipped 22.73% to $22.51 after the company reported downbeat quarterly results. Kamada (NASDAQ: KMDA) shares fell 17.04% to $5.94 after the company reported final results from the Phase 2/3 clinical trial of inhaled Alpha-1 antitrypsin to treat Alpha-1...

Kamada (NASDAQ: KMDA) shares dipped 19.05% to $5.78 in pre-market trading after the company reported final results from the Phase 2/3 clinical trial of inhaled Alpha-1 antitrypsin to treat Alpha-1 antitrypsin deficiency. Ciena (NYSE: CIEN) shares declined 9.82% to $18.45 in pre-market trading after...

IRadimed (NASDAQ: IRMD) shares slipped 39.81% to $6.26 after the company announced the receipt of the FDA warning letter regarding inspection of facility. Digital Ally (NASDAQ: DGLY) shares dipped 18.14% to $27.35 after gaining around 80% on Tuesday. Helen of Troy (NASDAQ: HELE) dropped 10.89% to $...

Guidewire Software (NYSE: GWRE) shares dipped 8.34% to $42.00 in pre-market trading after the company issued a weak FY15 forecast. However, the company reported stronger-than-expected fiscal fourth-quarter results. Helen of Troy (NASDAQ: HELE) shares declined 8.22% to $54.29 in pre-market trading...

Exelixis (NASDAQ: EXEL) shares tumbled 52.90% to $1.95 after the company announced its plans to lower around 70% of its workforce. The company reported that its phase 3 pivotal trial of cabozantinib did not meet primary endpoint. Conns (NASDAQ: CONN) dropped 28.61% to $32.01 after the company...

Exelixis (NASDAQ: EXEL) shares dipped 52.66% to $1.96 in pre-market trading after the company announced its plans to lower around 70% of its workforce. The company reported that its phase 3 pivotal trial of cabozantinib did not meet primary endpoint. Conns (NASDAQ: CONN) shares declined 25.38% to $...

UBIC (NASDAQ: UBIC) shares slipped 9.03% to $20.60. The directors of UBIC resolved to acquire all of the outstanding shares of TechLaw Solutions. Kandi Technolgies Group (NASDAQ: KNDI) shares dropped 8.37% to $17.52 after the company announced its entry into agreement for registered direct...